Impact of Statin Therapy on Adaptations to Aerobic Exercise

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

June 5, 2024

Study Completion Date

June 5, 2024

Conditions
Cardiovascular Diseases
Interventions
DRUG

Lipitor 20Mg Tablet

One tablet by mouth every day for 12 weeks.

DRUG

Lipitor 80Mg Tablet

One tablet by mouth every day for 12 weeks.

DRUG

Placebo

One matching placebo tablet by mouth every day for 12 weeks.

BEHAVIORAL

Exercise Program

Exercise program of brisk walking and/or slow jogging on a treadmill for 90 minutes of exercise spread over 3 days during week 1, 150 minutes of exercise spread over 5 days during week 2, 225 minutes of exercise over 5 days during week 3 and for the rest of the study.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Kansas Medical Center

OTHER

NCT03360916 - Impact of Statin Therapy on Adaptations to Aerobic Exercise | Biotech Hunter | Biotech Hunter